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Infectious diseases induced by bacteria affect millions 
of people worldwide. Although many generations of 
antibiotics have been developed, the continuous rise 
in bacterial drug resistance is becoming an increasing 
concern for public health, driving the need for new 
antibacterial therapies. Several promising 
antibacterial agents have emerged, including silver 
particles,1 metal oxide nanopartiles,2 antimicrobial 
peptides,3 and organic nanostructures.4 Recently, 
two-dimensional (2D) graphene materials have been 
considered as antibacterials, where direct contact of 
their sharp edges with bacterial membranes has been 
proposed to induce physical damage to bacteria.5, 6 
Using simulations, previous studies have theorised 
that the shape of such nanomaterials is crucial to their 
interaction with the lipid bilayer in translocation 
processes,7 which is believed to be directly related to 
antimicrobial activity. It was suggested that the ability 
of a nanoparticle to penetrate across a membrane is 
determined by the contact area between the particle 
and the membrane and the local curvature of the 
particle at the contact point.7 Additional parameters, 
such as rotation of the particle, are also important for 
non-spherical constructs, complicating the 
penetration process even further.8  
Cationic compounds are well-known as potential 
candidates for antibacterial agents, including 
surfactants,9, 10 peptides,11, 12 and cationic polymers.13 
In particular, self-assembled cationic polymer 
nanostructures exhibit an increase in charge density, 
allowing for easier membrane rupture and thus 
improved antibacterial activity.14 These nanoparticles 
also allow opportunities to improve antimicrobial 
properties further by modification of variables which 
have been considered to affect antimicrobial activity, 
including chemistry, size, shape and surface charge of 
the particle.15, 16 For example, Jang and co-workers 
found that smaller spherical particles exhibited higher 
antibacterial activity than larger spherical particles 
due to an increase in surface area.17 Notably, 
ABSTRACT: The size and shape of nanoparticles has been demonstrated to affect their biodistribution, 
cellular uptake, and biological activity. To explore these effects on antibacterial activity, crystallization 
driven self-assembly (CDSA) was utilized to prepare nanoparticles with spherical or platelet 
morphologies of different sizes. We report that small 2D platelets (< 1 m) exhibited greater 
antibacterial activity than larger 2D platelets (ca. 4 m), their corresponding spherical constructs, and 
unassembled polymer chains. We also observed that the size, shape, and membrane structure of the 
bacteria were critical in determining the biological activity of the nanoparticles, with platelets whose 
size was on the same order of magnitude as the bacteria exhibiting the greatest antibacterial activity. 
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however, Chen and co-workers compared the 
antibacterial activity of polymer nano-objects with 
sheet-like, cylindrical and spherical shapes and found 
no significant difference in antibacterial performance 
across the series.18 One challenge, which is 
highlighted by these previous works, is that 
conventional self-assembly methods afford cylinders 
of high length dispersity and also sheets of undefined 
size and shape, this can limit the ability to interpret 
morphology and size effects. Hence, the effect of size 
of such non-spherical particles on antibacterial 
activity is much less investigated. 
Quaternized PDMAEMA has previously been 
considered as a promising antimicrobial agent19, 20 
and has been immobilized on the surface of various 
shaped substrates including spherical21 and 
cylindrical-shaped22, 23 structures to show 
antibacterial activity. However, the combined effect 
of particle shape and size on antibacterial activity is 
yet to be fully understood. Herein, we report the 
 
Scheme 1. Preparation of quaternised PLLA36-b-PDMAEMA216 cationic spheres and crystalline platelets.
antibacterial activity of quaternized poly(L-lactide)-
block-poly(dimethylaminoethyl methacrylate) (PLLA-
b-PDMAEMA) block copolymers assembled into 
spherical particles and diamond-shaped platelets of 2 
different sizes using a crystalline driven self-assembly 
(CDSA) approach.  
Based on synthetic methods that we recently 
established,24, 25 a PLLA36-b-PDMAEMA216 diblock 
copolymer with a crystallizable PLLA block and a 
stabilizing PDMAEMA bock was synthesised via ring-
opening polymerisation (ROP) of L-lactide followed by 
reversible addition-fragmentation chain transfer 
(RAFT) polymerization of DMAEMA from a dual-
functional chain transfer agent and ROP initiator 
(Scheme 1, Table S1). 1H NMR spectroscopic analysis 
was used to confirm the degree of polymerization 
(Fig. S1), and a narrow dispersity (1.26) of the polymer 
and monomodal distribution was confirmed by SEC 
refractive index (RI) analysis, with good overlap of the 
UV (λ = 309 nm) trace showing retention of the RAFT 
CTA end group (Fig. S2). 
A series of cationically-charged nanostructures were 
prepared using both CDSA and conventional self-
assembly (Scheme 1). Diamond-shaped platelets 
were prepared by heating the polymer (at 5 mg mL-1 
in ethanol) in a sealed vial for 4 h before cooling to 
room temperature and ageing for one day. Semi-
crystalline platelets ca. 600 ± 70 nm in length (on the 
longest axis) were formed as confirmed by 
transmission electron microscopy (TEM) and wide-
 3 
angle X-ray diffraction (WAXD) analysis (Figure 1a and 
Figure S3, respectively), with a thickness of ca. 12 nm 
as measured by atomic force microscopy (AFM, 
Figure S4). We have previously shown that increasing 
the solubility of the unimer in the assembly solvent 
allows for access to larger diamonds with no change 
in their thickness.26 Hence, diamond-shaped platelets 
of ca. 3700 ± 200 nm (long axis) were prepared using 
a 88:12 ethanol/THF solution following a similar 
assembly procedure (Figure 1d). We shall refer to the 
0.6 µM platelets as small plates, and the 3.7 µM 
plates as large platelets. Quantitative methyl-
quaternization of these two platelets sizes was 
achieved using CH3I post-assembly, as confirmed by 
1H NMR spectroscopy (Figure S5). TEM analysis 
confirmed no significant difference in the dimensions 
or dispersity of the platelets before and after 
modification, as previously reported (Figures 1b and 
1e).25, 26  
We also explored the dodecyl-quaterization of the 
constructs, as this modification has been reported to 
have improved activity given the more hydrophobic 
nature of the modification.27 However, due to the 
 
Figure 1. TEM micrographs (stained with uranyl acetate) of PLLA36-b-PDMAEMA216 small platelets (a) unquaternized, 
(b) quaternized with a methyl group and (c) quaternized with a dodecyl group; PLLA36-b-PDMAEMA216 large platelets 
(d) unquaternized, (e) quaternized with a methyl group and (f) quaternized with a dodecyl group; PLLA36-b-
PDMAEMA216 spheres (g) unquaternized and (e) quaternized with a methyl group. Scale bar = 1 µm. 
harsher conditions required for the dodecyl-
quaternization, this modification was carried out on 
the polymer prior to assembly (Figure S6). Again, 1H 
NMR spectroscopy confirmed quantitative 
quaternization. Despite this change in parent polymer 
properties, the CDSA of the dodecyl quaternized 
polymer resulted in diamond-shaped small and large 
platelets of comparable size to those prepared from 
the non-modified polymer (Figures 1c and 1f). As a 
control nanostructure, the methyl-quaternized 
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polymer was self-assembled using conventional 
solvent-switch methods to afford a spherical particle. 
The spherical morphology was confirmed by TEM 
analysis (Figures 1g and 1h for un-quaternized and 
quaternized, respectively), and a diameter of 136 ± 35 
nm was measured by dynamic light scattering (DLS) 
analysis.  Positive zeta potential values were 
measured for all of the quaternized constructs, 
confirming cationic charge was present on all particle 
surfaces (Table S2). 
Given the previous work on the antibacterial testing 
of PDMAEMA we first explored the activity relative to 
S. aureus. Antibacterial testing was carried out by 
applying a set of pre-determined concentrations 
(62.5 µg/mL to 1000 µg/mL) of platelet dispersions in 
water onto the surface of a glass petri dish, followed 
by slow evaporation of water. A bacterial solution of 
S. aureus was then added to petri dishes (4 repeats) 
and incubated for 2 h. 
As expected, dense bacterial colonies were observed 
in the control sample without any platelet additives 
(Figure S6).  When the large platelets were used, a 
decrease in the number of bacterial colonies were 
observed above a concentration of 125 µg mL-1 of 
platelets, with no bacterial growth observed for a 
platelet concentration of 1000 µg mL-1. When small 
platelets were used, much lower particle 
Table 1. MIC test with methyl-quaternized nanostructures and polymers. 
Bacteria property MIC (µg mL-1) 
Bacteriaa + or – b Shape Size (µm) 
Small 
platelets 
Large 
platelets 
Spheres Homopolymer 
S. aureus + Sphere 0.5 64 128 128 256 
M. luteus + Sphere 1 128 >512 256 >512 
N. gonorrhoeae – Sphere 1 256 256 256 256 
P. aeruginosa – Rod 0.5 128 256 256 >512 
E. coli – Rod 1.5 >512 >512 >512 >512 
L. monocytogenes + Rod 1.5 128 128 128 256 
B. subtilis + Rod 2 128 128 128 128 
aBacteria abbreviations: Staphylococcus aureus, Escherichia coli, Listeria monocytogenes, Bacillus subtilis, Micrococcus luteus, 
Neisseria gonorrhoeae, Pseudomonas aeruginosa. b + or – indicates gram-positive and gram-negative bacteria, respectively.
concentrations were needed to inhibit bacterial 
growth, with a decrease in bacterial colonies relative 
to the control sample observed as low as 62.5 µg mL-
1 of platelets and no bacterial growth observed at 
500 µg mL-1.  
To quantify the antibacterial activity, the killing 
efficacy was calculated quantitatively by determining 
the antibacterial rate and log reduction values from 
optical density (OD) mesurements.28, 29 As shown in 
Figure S8 and Table S3, at a nanostructure 
concentration of 250 µg mL-1 of small or large 
platelets, the Log reduction values obtained were 
2.63 and 1.42, respectively, confirming the greater 
antibacterial activity for the smaller platelets. Indeed, 
less than half the concentration of small platelets was 
needed to exhibit the same antibacterial activity as 
the large platelets. Indeed, this trend in greater 
activity of small platelets was consistent across all 
concentrations studied (Figure S7, Table S3). 
As a control, the antibacterial activity of spherical 
particles prepared from the same polymer were also 
examined (Figure S8). Across the concentration series 
(62.5 µg/mL, to 2500 µg/mL), a lower antibacterial 
activity was measured for spheres in comparison to 
the small platelets, as calculated by antibacterial rate 
and log reduction values (Fig. S7 and Table S3), 
although MICs did not follow this trend. However, a 
higher antibacterial activity was observed for spheres 
in comparison to the larger platelets, showing that 
not only morphology, but also the size of the 
assembly plays a key role in determining antibacterial 
activity. While the mechanism of action of the 
platelets against bacterial cells is currently unclear, it 
is possible that the high charge density and compact 
size of the small platelets allows for tighter contacts 
with the bacteria in solution. A corresponding 
PDMAEMA homopolymer was also used as an 
additional control, which, as expected, exhibited a 
much lower antibacterial activity. Even at a 
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concentration of 5000 µg mL-1 the homopolymer was 
unable to completely inhibit bacterial growth.  
We also tested the antibacterial activity of the 
constructs against E. coli. As shown in Table 1, all of 
the nanostructures were found to be ineffective in 
limiting the growth of E. coli, with MICs of > 512 µg 
mL-1. Given that E. coli has a different size, shape, and 
outer membrane structure than S. aureus (and is also 
Gram-negative rather than Gram-positive) we 
decided to explore the MIC of these constructs across 
a range of different bacteria (Table 1). Initially, the 
antimicrobial activity of the quaternized particles 
against M. luteus, a Gram-positive spherical bacteria 
of ca. 1 µm in diameter, followed a trend similar to 
that the S. aureus sample (which is also a spherical 
bacterium but only around 0.5 m in diameter), with 
small platelets exhibiting the lowest MIC. As observed 
for E. coli, no notable difference in MIC between the 
different constructs was observed with N. 
gonorrhoeae, a Gram-negative bacterium of similar 
shape and size to M. luteus.  
To further elucidate the impact of bacterial size and 
shape on the effectiveness of the quaternized 
particles, MIC tests were conducted using P. 
aeruginosa, a Gram-negative bacteria of rod-shape 
similar to that of E. coli but of a size similar to S. 
aureus. As shown in Table 1, a lower MIC value was 
obtained when treating P. aeruginosa with small 
platelets in comparison to the large platelets and 
spheres. This suggested that effectiveness of the 
constructs is highest when the size of the construct is 
similar to the bacteria size. To further expand this 
study, two Gram-positive bacteria B. subtilis and L. 
monocytogenes, with larger sizes and which are rod-
shaped were also tested. However, the antibacterial 
activity of the range of different nanostructures 
against these 2 bacteria did not appear to vary as a 
function of particle size or shape, which we propose 
is as a result of the mismatch of size the bacteria and 
construct.  
Table 2. MIC test with dodecyl-quaternized 
polymers. 
Bacteriaa MIC (µg mL-1) 
Small platelets Large platelets 
E. coli N43 64 64 
E. coli D22 64 256 
E. coli NCTC 64 128 
aBacteria abbreviations: Escherichia coli 
Previous work has demonstrated that increasing the 
length of the alkyl quaternized chain improves the 
antibacterial activity of polymeric materials.27, 30 This 
dependence of activity on alkyl chain length has been 
rationalized in terms of their differential adsorption 
and cell membrane insertion, which is especially 
important in Gram-negative bacteria which has a 
much thicker membrane and hence is more 
hydrophobic. Hence, the effect of the quaternary 
ammonium structure on antibacterial activity was 
investigated by preparing small and large diamond-
shaped platelets with a more hydrophobic dodecyl 
alkyl ammonium group. This was explored against 
several common strains of E. coli. As shown in Table 
2, smaller platelets demonstrated a much lower MIC 
value for 2 of the strains, E. coli D22 and E. coli NCTC. 
However, an equivalent and MIC value for both 
platelet sizes was found for E. coli N43; however, this 
bacterial strain is known to be hypersensitive to 
drugs, which may explain this low value. As expected, 
these values were significantly lower than those 
obtained using the particles quaternized with methyl 
iodide, however, the trends in relation to particle size 
were still observed. 
In summary, we have compared the antibacterial 
activity of quaternized PLLA36-b-PDMAEMA216 small 
and large platelet structures, where it was found that, 
in general, small platelets (ca. 0.6 µM in size) 
exhibited higher antibacterial activity than large 
platelets or spherical structures. This trend appeared 
to be consistent for bacteria with different shapes, 
sizes, and outer membrane structures. We envision 
that these findings could inform the design of future 
antibacterial formulations; however, further studies 
are warranted to elucidate the mechanism of action 
of quaternized platelets against bacterial cells. 
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GRAPHICAL ABSTRACT 
 
Maria Inam, Jeffrey C. Foster, Jingyi Gao, Yuanxiu Hong, Jianzhong Du, Andrew P. Dove, Rachel K. 
O’Reilly 
Size and Shape Affects the Antimicrobial Activity of Quaternized Nanoparticles 
Crystallization driven self-assembly (CDSA) was utilized to prepare quaternized nanoparticles with 
spherical or platelet morphologies of different sizes to explore the effect of size and shape on their 
antibacterial activity. Small 2D platelets (< 1 m) exhibited greater antibacterial activity than larger 2D 
platelets (ca. 4 m), their corresponding spherical constructs, and unassembled polymer chains. This 
activity was dependent on the size, shape, and cell membrane structure of the bacteria. 
 
 
 
